We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Lung Cancer

Journal Scan / Research · March 29, 2021

Response to Treatment and Genomic Characteristics of Lung Adenocarcinoma With EGFR Exon 20 Insertions

Clinical Cancer Research


Additional Info

Clinical Cancer Research
Response to Standard Therapies and Comprehensive Genomic Analysis for Patients With Lung Adenocarcinoma With EGFR Exon 20 Insertions
Clin. Cancer Res 2021 Mar 08;[EPub Ahead of Print], NJ Choudhury, AJ Schoenfeld, J Flynn, CJ Falcon, H Rizvi, CM Rudin, MG Kris, ME Arcila, G Heller, HA Yu, M Ladanyi, GJ Riely

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading